Zai Lab Ltd — Regulatory Filings 2020

Sep 11, 2020

6-K 1 a20-29356_66k.htm 6-K

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 6-K*

*REPORT OF FOREIGN PRIVATE ISSUER*

*PURSUANT TO RULE 13A-16 OR 15D-16*

*OF THE SECURITIES EXCHANGE ACT OF 1934*

*For the month of September 2020*

*Commission Filing Number: 001-38205*

*ZAI LAB LIMITED*

(Translation of registrant’s name into English)

*4560 Jinke Road, Bldg. 1, 4F, Pudong, Shanghai, China 201210*

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

SEQ.=1,FOLIO='',FILE='C:\JMS\111375\20-29356-6\task9866089\29356-6-ba.htm',USER='111375',CD='Sep 11 11:31 2020'

*EXHIBIT INDEX*

Exhibit No.	Description
99.1	Zai Lab Limited Supplemental and Updated Disclosures

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\111375\20-29356-6\task9866089\29356-6-ba.htm',USER='111375',CD='Sep 11 11:31 2020'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

By:	/s/ Billy Cho
Name:	Billy Cho
Title:	Chief Financial Officer
Date: September 11, 2020

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\111375\20-29356-6\task9866089\29356-6-ba.htm',USER='111375',CD='Sep 11 11:31 2020'